openPR Logo
Press release

Parkinson’s Disease Therapeutics Market to Reflect Robust Expansion During 2016-2026

03-26-2018 07:25 AM CET | Health & Medicine

Press release from: Future Market Insights

/ PR Agency: Future Market Insights
Parkinson’s Disease Therapeutics Market to Reflect Robust

Parkinson’s disease is a central nervous system disorder affecting motor neuron activities, characterized by tremor, rigidity, dementia, depression etc. According to GDB 2013 Mortality and Causes of Death Collaborators report, in 2013, 53 Mn people were living with Parkinson’s disease while the disease caused 103,000 deaths globally. Risk of Parkinson’s disease increases with age and the disease mainly affects person over 50 years of age. Treatment for the Parkinson’s disease in mainly symptomatic and no curative treatment options are available. The main aim of the Parkinson’s disease treatment is to provide control on signs and symptoms such as shakiness in hands, difficulty with walking, slowness of movement etc. Therapeutic approach for each person varies according to his or her symptoms. Treatment options include medication or surgical treatment. Levodopa in combination with carbidopa is considered as a gold standard for symptomatic treatment of Parkinson’s disease. Surgical treatment options include deep brain stimulation and Carbidopa/levodopa enteral suspension therapy. However, surgical therapy is effective only for patients who have previously responded to Levodopa therapy. Some of the commercially available drugs for treatment of Parkinson’s disease are Cycloset, Parlodel (Bromocriptine Mesylate), Requip (ropinirole), Rytary, Azilect, Northera, Stalevo, Comtess/Comtan and others. Over the past decade, great progress has been made in the treatment of Parkinson’s disease such as identification of new therapeutic targets through genetic research, understanding the common mutations that contribute to Parkinson’s disease etc.

Parkinson’s disease Therapeutics Market: Drivers and Restraints

Recent advances in Parkinson’s disease therapeutics such as combination therapies to prolong the action of continuous dopaminergic stimulation drugs, approval for Neurostimulation devices neuroprotective therapies to slow down prognosis of a disease, gene therapy, neural transplantation etc. are expected to bring massive growth in global Parkinson’s disease therapeutics market over the forecast period. Moreover, increasing aging population, prevalence of Parkinsonism across the world are the factors fueling demand for Parkinson’s disease therapeutics. But generic erosion due to expiry of patents for several drugs such as Rytary, Stalevo (2012), Azilect (2017), Comtan (exclusivity expired in 2013) etc. would deter the growth of global Parkinson’s disease therapeutics market.

Request to Sample Report - https://www.futuremarketinsights.com/reports/sample/rep-gb-2527

Parkinson’s disease Therapeutics Market: Segmentation

The global Parkinson’s disease therapeutics market is classified on the basis of treatment type, end user and geography.

Based on treatment type, the global Parkinson’s disease therapeutics market is segmented into the following:

Medications
Dopamine Precursors
Peripheral Decarboxylase Inhibitors
COMT Inhibitors
MAO Inhibitors
Others (anticholinergics, antihistaminics etc.)
Medical Devices
Deep Brain Stimulation (DBS) Devices
Carbidopa/Levodopa Enteral Suspension (Duopa) delivery devices

Based on end user, the global Parkinson’s disease therapeutics market is segmented into the following:

Hospitals
Clinics
Homecare Settings

Parkinson’s disease Therapeutics Market: Overview

Global Parkinson’s disease therapeutics market is expected to witness healthy CAGR over the forecast period as few new therapies are expected to hit the market during the forecast period such as repetitive transcranial magnetic stimulation device, adipose derived stem cell therapy, non-invasive Neurostimulation device etc. Increasing burden of Parkinson’s disease management on healthcare systems of major countries such as the U.S. and U.K. would stimulate the exhaustive efforts by the government to increase the pace of R&D in Parkinson’s disease therapeutics. For instance, in the U.S. over 40 medicines are being developed for the treatment and diagnosis of Parkinson’s disease many of which have gained fast track designation from the U.S. FDA.

Request Report TOC @ https://www.futuremarketinsights.com/toc/rep-gb-2527

Parkinson’s disease Therapeutics Market: Regional Overview

Region wise, the global Parkinson’s disease therapeutics market is classified into seven regions namely, North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. North America has conventionally dominated the global market for Parkinson’s disease therapeutics due to good reimbursement policies and high prevalence of the disease. According to Parkinson’s disease Foundation (PDF) approximately 60,000 Americans are diagnosed with Parkinson’s disease annually. Europe is expected to hold second highest share in the global market owing to increasing R&D efforts by the key players in the region.

Parkinson’s disease Therapeutics Market: Key Players

Some of the key players in global Parkinson’s disease therapeutics market include GlaxoSmithKline Plc., Salix Pharmaceuticals, mpax Laboratories, Inc., Teva Pharmaceutical Industries Ltd., Novartis AG, Orion Corporation, Mylan N.V. while generic players include Par Pharmaceutical, Cipla Inc., Daiichi Sankyo, Apotex Inc., Wockhardt Limited and others.

ABOUT US:
Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services, which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, an aerial view of the competitive framework, and future market trends.

CONTACT:
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Website :www.futuremarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Parkinson’s Disease Therapeutics Market to Reflect Robust Expansion During 2016-2026 here

News-ID: 991353 • Views: 143

More Releases from Future Market Insights

How Changing Dynamics of Cable Testing Market are Reflecting on Growth Strategie …
Global Cable Testing Market: Introduction The cost of the substitution of cables that are concealed is very high. Faults in the cable, bending, kinking, and crushing, are not always visible, which has created the requirement for cable testing. Thus, cable testing helps check the cable functionality, cable quality, and cable conformity. Several times, cable testing by visual inspection is an effective way of identifying the actual problem before it causes any
How Transformative Trends in Self-Organising Network Market are Molding Strategi …
Self-Organising Network: Introduction With accelerated advancements and increasing complexities in the radio network technologies, such as those utilised for the development of LTE and 5G networks, which are used for planning, management, configuration, healing and optimisation, are required to be automated to facilitate efficiency. At present, suppliers are offering self-organising networks that possess the ability to offer optimum performance. Self-organising networks are use cases that perform network governance, including network planning,
Mining Vehicle AC Kits Market: Exploring the Impact of Trends on Strategies of K …
Mining Vehicle AC Kits Market: Introduction Cabin space in mining equipment has become more sophisticated in the recent past. The installation of mining vehicle AC kits has evolved from an optional feature to a necessary feature. Mining equipment manufacturers have made advancements in technology related to efficiency, performance and cost of air conditioning systems in order to make them affordable and economical to enable low-budget and compact installations without compromising on
Key Factors to Fuel Growth of the Talent Acquisition & Staffing Technology and S …
With the growing importance of recruiting and retaining top talent effectively and efficiently, smart hiring processes are the need of the hour. It is about time organisations move beyond merely scrutinising resumes. Salaries and benefits are important factors, but adopting ways that would make candidates an important part of the hiring process will attract the best talent. Studies reveal that due to discrepancies in existing Applicant Tracking Systems (ATS), hiring

All 5 Releases


More Releases for Par

Global LED PAR Cans Market Insights, Forecast
This report presents the worldwide LED PAR Cans market size (value, production and consumption), splits the breakdown (data status 2013-2018 and forecast to 2025), by manufacturers, region, type and application. This study also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis. Get sample copy of the report: https://www.marketdensity.com/contact?ref=Sample&reportid=60622 Table of Contents: Table of Contents 1 Study
Tuberculin Market 2017 - Sanofi Pasteur, Zoetis, Par Sterile, SSI
Apex Research, recently published a detailed market research study focused on the "Tuberculin Market" across the global, regional and country level. The report provides 360° analysis of "Tuberculin Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Tuberculin industry, and estimates the future trend of Tuberculin market on the basis of this
GREEN CREATIVE launches new PAR REFINE Series
SAN BRUNO, CA, July 21th, GREEN CREATIVE, the commercial grade LED lighting manufacturer proudly announces the launch of its latest generation of PAR lamps. The new award-winning PAR REFINE Series includes PAR38, PAR30 long and short neck and PAR20 lamp types in spot, narrow flood and flood beam angles. This year the IES selected the PAR REFINE Series for its 2017 Progress Report, and the PAR38 was chosen by Lighting for
Global PAR Light Market 2017 : PULSAR, Spotlight, Teclumen, Eurolite & Evolight
This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - LEDPRO - EVITON Lighting - PR Lighting - PROEL GROUP - PULSAR - Spotlight - Teclumen - TIMES SQUARE LIGHTING - A&O Lighting Technology The survey report by Market Research Store is an overview of the global PAR Light market. It covers all the recent trends including key developments in the global market in present and in future. Analyses
Etomidate Market 2017- Mylan, Luitpold, Par Sterile Products, Zydus, Emcure
Here comes the New Version of Etomidate Market Research Report is a core market research report in this current market. This report majorly discuss the global and regional market, major manufacturers and segment market details various classifications and mode of applications. Do u Want Sample of report then visit at: https://www.1marketresearch.com/sample/?flag=rs&rep_id=3237&sku=1808 Here is Top Manufacturers which covers in this report: Mylan Luitpold Par Sterile Products Zydus Emcure Chengdu Suncadia Jiangsu Nhwa Zhejiang Jiuxu Merck KGaA First and foremost, Etomidate report gives the basic
Vibes, Par Excellence- Makes A Mark in Bangladesh
VIBES, a renowed & trusted chain of High-end Weight Management, Beauty and Laser Clinics is a part of The Alankar Group. Under the leadership of Mrs. Lathaa Jain, Chairperson, VIBEScommenced its business operations in 1996, with its first centre at New Delhi, INDIA. VIBES as a brand was launched by Ms. DiaMirza (Miss Asia Pacific International) in 2005 and now it has 25Clinics spread across INDIA & BANGLADESHdelivering world class